Gna Biosolutions

Develops instruments, OEM modules and assays for molecular pathogen detection

placePlanegg, Bavaria, Germany calendar_todayFounded 2010 groups29 employees language gna-bio.com

Registered entities

Innovation

17 patent families (15 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 672 times.

YearFilings
20121
20132
20143
20154
20166
20175
20188
20197
20206
20214
20223
20234

Investor mix

13 investors on record; lead investors include OCCIDENT, GreyBird Ventures, Bayern Kapital; 2 have since exited.

Investor typeCountShare
Venture capital1077%
Private equity18%
Other / undisclosed215%
Coming soon